One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

There has been no previous prospective study evaluating dual antiplatelet therapy (DAPT) duration shorter than 6 months after cobalt-chromium everolimus-eluting stent (CoCr-EES) implantation. STOPDAPT trial is a prospective multi-center single-arm study evaluating 3-month DAPT duration after CoCr-EE...

Descripción completa

Detalles Bibliográficos
Autores principales: Natsuaki, Masahiro, Morimoto, Takeshi, Yamamoto, Erika, Shiomi, Hiroki, Furukawa, Yutaka, Abe, Mitsuru, Nakao, Koichi, Ishikawa, Tetsuya, Kawai, Kazuya, Yunoki, Kei, Shimizu, Shogo, Akao, Masaharu, Miki, Shinji, Yamamoto, Masashi, Okada, Hisayuki, Hoshino, Kozo, Kadota, Kazushige, Morino, Yoshihiro, Igarashi, Keiichi, Tanabe, Kengo, Kozuma, Ken, Kimura, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923071/
https://www.ncbi.nlm.nih.gov/pubmed/26518420
http://dx.doi.org/10.1007/s12928-015-0366-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923071/
https://www.ncbi.nlm.nih.gov/pubmed/26518420
http://dx.doi.org/10.1007/s12928-015-0366-9

Ejemplares similares